Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period:
Insider Trading Transactions for 5AM Opportunities I (GP) LLC
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
Company Symbol Insider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2022-04-11
Sale
2022-04-13
4:51 pm
scPharmaceuticals Inc. SCPH 5AM Partners IV LLC
5AM Co-Investors IV L.P.
5AM Opportunities I (GP) LLC
5AM Opportunities I L.P.
5AM Ventures IV L.P.
DIEKMAN JOHN D
ROCKLAGE SCOTT M
Schwab Andrew J.
10% Owner
270,000 $5 $1,350,000 537,301
(Indirect)
View
2022-02-08
Sale
2022-02-10
6:24 pm
Rallybio Corp RLYB 5AM Opportunities I L.P.
Schwab Andrew J.
5AM Opportunities I (GP) LLC
5AM Partners V LLC
5AM Ventures V L.P.
ROCKLAGE SCOTT M
10% Owner
210,000 $13.05 $2,740,500 2,645,087
(Indirect)
View
2022-01-11
Purchase
2022-01-13
4:45 pm
CinCor Pharma Inc. CINC 5AM Partners VI LLC
5AM Ventures VI L.P.
5AM Opportunities I (GP) LLC
5AM Opportunities I L.P.
Schwab Andrew J.
PARMAR KUSH
10% Owner
470,000 $16 $7,520,000 496,323
(Indirect)
View
2021-11-16
Sale
2021-11-18
8:14 pm
Vor Biopharma Inc. VOR 5AM Ventures VI L.P.
5AM Partners VI LLC
5AM Opportunities I L.P.
5AM Opportunities I (GP) LLC
Schwab Andrew J.
10% Owner
330,706 $15.3 $5,059,802 1,766,634
(Indirect)
View
2021-11-02
Purchase
2021-11-04
9:10 pm
Entrada Therapeutics Inc. TRDA 5AM Ventures V L.P.
5AM Partners V LLC
5AM Opportunities I L.P.
5AM Opportunities I (GP) LLC
ROCKLAGE SCOTT M
Schwab Andrew J.
10% Owner
250,000 $20 $5,000,000 1,132,357
(Indirect)
View
2021-11-01
Sale
2021-11-03
4:38 pm
Cabaletta Bio Inc. CABA 5AM Ventures V L.P.
5AM Opportunities I (GP) LLC
5AM Opportunities I L.P.
5AM Partners V LLC
PARMAR KUSH
ROCKLAGE SCOTT M
Schwab Andrew J.
10% Owner
295,000 $13 $3,835,000 333,144
(Indirect)
View
2021-09-07
Sale
2021-09-09
5:34 pm
Cabaletta Bio Inc. CABA 5AM Ventures V L.P.
5AM Opportunities I (GP) LLC
5AM Opportunities I L.P.
5AM Partners V LLC
PARMAR KUSH
ROCKLAGE SCOTT M
Schwab Andrew J.
10% Owner
625,000 $9.7 $6,062,500 2,359,263
(Indirect)
View
2021-08-02
Purchase
2021-08-04
9:17 pm
Rallybio Corp RLYB 5AM Opportunities I L.P.
Schwab Andrew J.
5AM Opportunities I (GP) LLC
5AM Partners V LLC
5AM Ventures V L.P.
ROCKLAGE SCOTT M
10% Owner
615,384 $13 $7,999,992 4,190,724
(Indirect)
View
2021-04-27
Purchase
2021-04-29
8:51 pm
IMPEL NEUROPHARMA INC IMPL 5AM Ventures V L.P.
5AM Partners V LLC
PARMAR KUSH
ROCKLAGE SCOTT M
Schwab Andrew J.
5AM Opportunities I L.P.
5AM Opportunities I (GP) LLC
10% Owner
575,000 $15 $8,625,000 575,000
(Indirect)
View
2021-02-09
Purchase
2021-02-09
6:03 pm
Vor Biopharma Inc. VOR 5AM Ventures VI L.P.
5AM Partners VI LLC
5AM Opportunities I L.P.
5AM Opportunities I (GP) LLC
Schwab Andrew J.
10% Owner
555,555 $18 $9,999,990 1,858,470
(Indirect)
View
2021-01-08
Sale
2021-01-12
5:07 pm
Cabaletta Bio Inc. CABA 5AM Ventures V L.P.
5AM Opportunities I (GP) LLC
5AM Opportunities I L.P.
5AM Partners V LLC
PARMAR KUSH
ROCKLAGE SCOTT M
Schwab Andrew J.
10% Owner
387,000 $13 $5,031,000 369,688
(Indirect)
View
2020-12-29
Sale
2020-12-31
9:31 pm
Akouos Inc. AKUS 5AM Ventures V L.P.
5AM Partners V LLC
5AM Opportunities I L.P.
5AM Opportunities I (GP) LLC
ROCKLAGE SCOTT M
Schwab Andrew J.
10% Owner
470,000 $18 $8,460,000 982,453
(Indirect)
View
2020-12-10
Sale
2020-12-14
5:58 pm
Cabaletta Bio Inc. CABA 5AM Ventures V L.P.
5AM Opportunities I (GP) LLC
5AM Opportunities I L.P.
5AM Partners V LLC
PARMAR KUSH
ROCKLAGE SCOTT M
Schwab Andrew J.
10% Owner
298,000 $14.75 $4,395,500 417,629
(Indirect)
View
2020-11-11
Sale
2020-11-13
8:53 pm
IDEAYA Biosciences Inc. IDYA 5AM Ventures IV L.P.
5AM Co-Investors IV L.P.
5AM Partners IV LLC
5AM Opportunities I L.P.
5AM Opportunities I (GP) LLC
DIEKMAN JOHN D
Schwab Andrew J.
ROCKLAGE SCOTT M
10% Owner
800,000 $13.66 $10,928,000 384,496
(Indirect)
View
2020-10-05
Sale
2020-10-07
9:30 pm
Aprea Therapeutics Inc. APRE 5AM Ventures IV L.P.
5AM Co-Investors IV L.P.
5AM Partners IV LLC
5AM Opportunities I L.P.
5AM Opportunities I (GP) LLC
DIEKMAN JOHN D
Schwab Andrew J.
PARMAR KUSH
ROCKLAGE SCOTT M
Former 10% holder
175,000 $25.3 $4,427,500 2,037,654
(Indirect)
View
2020-06-30
Purchase
2020-07-02
8:50 pm
Akouos Inc. AKUS 5AM Ventures V L.P.
5AM Partners V LLC
5AM Opportunities I L.P.
5AM Opportunities I (GP) LLC
ROCKLAGE SCOTT M
Schwab Andrew J.
10% Owner
294,117 $17 $4,999,989 1,094,101
(Indirect)
View
2020-06-16
Sale
2020-06-18
7:22 pm
Aprea Therapeutics Inc. APRE 5AM Ventures IV L.P.
5AM Co-Investors IV L.P.
5AM Partners IV LLC
DIEKMAN JOHN D
Schwab Andrew J.
5AM Opportunities I L.P.
5AM Opportunities I (GP) LLC
PARMAR KUSH
10% Owner
140,000 $33.3 $4,662,000 313,497
(Indirect)
View
2020-06-11
Sale
2020-06-15
9:12 pm
Aprea Therapeutics Inc. APRE 5AM Ventures IV L.P.
5AM Co-Investors IV L.P.
5AM Partners IV LLC
DIEKMAN JOHN D
Schwab Andrew J.
5AM Opportunities I L.P.
5AM Opportunities I (GP) LLC
PARMAR KUSH
10% Owner
245,000 $28.75 $7,044,412 414,105
(Indirect)
View
2020-05-19
Sale
2020-05-21
9:31 pm
Aprea Therapeutics Inc. APRE 5AM Ventures IV L.P.
5AM Co-Investors IV L.P.
5AM Partners IV LLC
DIEKMAN JOHN D
Schwab Andrew J.
5AM Opportunities I L.P.
5AM Opportunities I (GP) LLC
PARMAR KUSH
10% Owner
255,000 $35.15 $8,963,250 423,905
(Indirect)
View
2019-10-29
Purchase
2019-10-31
6:03 pm
Cabaletta Bio Inc. CABA 5AM Ventures V L.P.
5AM Partners V LLC
5AM Opportunities I L.P.
5AM Opportunities I (GP) LLC
PARMAR KUSH
ROCKLAGE SCOTT M
Schwab Andrew J.
10% Owner
454,545 $11 $4,999,995 454,545
(Indirect)
View
2019-10-07
Purchase
2019-10-09
6:23 pm
Aprea Therapeutics Inc. APRE 5AM Ventures IV L.P.
5AM Co-Investors IV L.P.
5AM Partners IV LLC
5AM Opportunities I L.P.
5AM Opportunities I (GP) LLC
DIEKMAN JOHN D
Schwab Andrew J.
PARMAR KUSH
10% Owner
333,333 $15 $4,999,995 333,333
(Indirect)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
Company Symnbol Insider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2022-01-11
Conversion
2022-01-13
4:45 pm
N/A
N/A
CinCor Pharma Inc. CINC 5AM Partners VI LLC
5AM Ventures VI L.P.
5AM Opportunities I (GP) LLC
5AM Opportunities I L.P.
Schwab Andrew J.
PARMAR KUSH
10% Owner
17,017,645 $0 496,323
(Indirect)
View
2022-01-06
Ownership
2022-01-06
9:02 pm
N/A
N/A
CinCor Pharma Inc. CINC 5AM Partners VI LLC
5AM Ventures VI L.P.
5AM Opportunities I (GP) LLC
5AM Opportunities I L.P.
Schwab Andrew J.
PARMAR KUSH
10% Owner
0 $0 3,867,646
(Indirect)
View
2021-12-03
Ownership
2021-12-13
4:26 pm
N/A
N/A
Pear Therapeutics Inc. PEAR 5AM Partners IV LLC
5AM Ventures IV L.P.
5AM Co-Investors IV L.P.
5AM Opportunities I (GP) LLC
5AM Opportunities I L.P.
DIEKMAN JOHN D
ROCKLAGE SCOTT M
10% Owner
0 $0 18,631,771
(Indirect)
View
2021-11-02
Conversion
2021-11-04
9:10 pm
N/A
N/A
Entrada Therapeutics Inc. TRDA 5AM Ventures V L.P.
5AM Partners V LLC
5AM Opportunities I L.P.
5AM Opportunities I (GP) LLC
ROCKLAGE SCOTT M
Schwab Andrew J.
10% Owner
31,520,600 $0 1,132,357
(Indirect)
View
2021-10-28
Ownership
2021-10-28
9:30 pm
N/A
N/A
Entrada Therapeutics Inc. TRDA 5AM Ventures V L.P.
5AM Partners V LLC
5AM Opportunities I L.P.
5AM Opportunities I (GP) LLC
ROCKLAGE SCOTT M
Schwab Andrew J.
10% Owner
0 $0 4,158,379
(Indirect)
View
2021-07-29(A)
Ownership
2021-08-04
9:17 pm
N/A
N/A
Rallybio Corp RLYB 5AM Ventures V L.P.
5AM Partners V LLC
5AM Opportunities I L.P.
5AM Opportunities I (GP) LLC
ROCKLAGE SCOTT M
Schwab Andrew J.
10% Owner
0 $0 3,575,340
(Indirect)
View
2021-07-29
Ownership
2021-07-29
9:11 pm
N/A
N/A
Rallybio Corp RLYB 5AM Ventures V L.P.
5AM Partners V LLC
5AM Opportunities I L.P.
5AM Opportunities I (GP) LLC
ROCKLAGE SCOTT M
Schwab Andrew J.
10% Owner
0 $0 3,567,110
(Indirect)
View
2021-04-27
Conversion
2021-04-29
8:51 pm
N/A
N/A
IMPEL NEUROPHARMA INC IMPL 5AM Ventures V L.P.
5AM Partners V LLC
PARMAR KUSH
ROCKLAGE SCOTT M
Schwab Andrew J.
5AM Opportunities I L.P.
5AM Opportunities I (GP) LLC
10% Owner
39,725,924 $0 575,000
(Indirect)
View
2021-04-27
Conversion
2021-04-29
8:51 pm
N/A
N/A
IMPEL NEUROPHARMA INC IMPL 5AM Ventures V L.P.
5AM Partners V LLC
PARMAR KUSH
ROCKLAGE SCOTT M
Schwab Andrew J.
5AM Opportunities I L.P.
5AM Opportunities I (GP) LLC
10% Owner
101,457 $13.5 575,000
(Indirect)
View
2021-02-09
Conversion
2021-02-09
6:03 pm
N/A
N/A
Vor Biopharma Inc. VOR 5AM Ventures VI L.P.
5AM Partners VI LLC
5AM Opportunities I L.P.
5AM Opportunities I (GP) LLC
Schwab Andrew J.
10% Owner
88,184,384 $0 1,858,470
(Indirect)
View
2021-02-04
Ownership
2021-02-04
9:50 pm
N/A
N/A
Vor Biopharma Inc. VOR 5AM Ventures VI L.P.
5AM Partners VI LLC
5AM Opportunities I L.P.
5AM Opportunities I (GP) LLC
Schwab Andrew J.
10% Owner
0 $0 6,136,874
(Indirect)
View
2020-06-30
Conversion
2020-07-02
8:50 pm
N/A
N/A
Akouos Inc. AKUS 5AM Ventures V L.P.
5AM Partners V LLC
5AM Opportunities I L.P.
5AM Opportunities I (GP) LLC
ROCKLAGE SCOTT M
Schwab Andrew J.
10% Owner
95,171,485 $0 1,094,101
(Indirect)
View
2020-06-25
Ownership
2020-06-25
8:46 pm
N/A
N/A
Akouos Inc. AKUS 5AM Ventures V L.P.
5AM Partners V LLC
5AM Opportunities I L.P.
5AM Opportunities I (GP) LLC
ROCKLAGE SCOTT M
Schwab Andrew J.
10% Owner
0 $0 4,311,667
(Indirect)
View
2020-05-26
Ownership
2020-05-28
9:11 pm
N/A
N/A
scPharmaceuticals Inc. SCPH 5AM Opportunities I (GP) LLC
5AM Opportunities I L.P.
See Remarks
0 $0 578,034
(Indirect)
View
2019-10-29
Conversion
2019-10-31
6:03 pm
N/A
N/A
Cabaletta Bio Inc. CABA 5AM Ventures V L.P.
5AM Partners V LLC
5AM Opportunities I L.P.
5AM Opportunities I (GP) LLC
PARMAR KUSH
ROCKLAGE SCOTT M
Schwab Andrew J.
10% Owner
8,036,804 $0 454,545
(Indirect)
View
2019-10-07
Conversion
2019-10-09
6:23 pm
N/A
N/A
Aprea Therapeutics Inc. APRE 5AM Ventures IV L.P.
5AM Co-Investors IV L.P.
5AM Partners IV LLC
5AM Opportunities I L.P.
5AM Opportunities I (GP) LLC
DIEKMAN JOHN D
Schwab Andrew J.
PARMAR KUSH
10% Owner
2,506,650 $0 333,333
(Indirect)
View
(A) Indicate amendment filing.